Literature DB >> 12424183

Are inactivation procedures for blood products good or bad?

Gregor Caspari.   

Abstract

Mesh：

Year:  2002        PMID： 12424183      PMCID： PMC1124595          DOI： 10.1136/bmj.325.7372.1116/b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Blood transfusion medicine.

Authors:  Fiona Regan; Clare Taylor
Journal:  BMJ       Date:  2002-07-20

2.  Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study.

Authors:  P Perez; L R Salmi; G Folléa; J L Schmit; B de Barbeyrac; P Sudre; R Salamon
Journal:  Transfusion       Date:  2001-07       Impact factor: 3.157

3.  Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).

Authors:  Jeroen de Jonge; Theo H N Groenland; Herold J Metselaar; Jan N M IJzermans; Huub H D M van Vliet; Loes Visser; Hugo W Tilanus
Journal:  Anesth Analg       Date:  2002-05       Impact factor: 5.108
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.